EZ BIOPAC®

Proven to Reduce Fill Time and Cross Contamination

  • EZ BioPac®, ILC Dover’s purpose-built powder containment and transfer system, speeds fill time and makes it easy to adjust contents to precise target weight
  • It’s separate discharge outlet and antistatic polymer material mean faster, cleaner discharge with residuals consistently 2g or less in a 5 kg bag
  • The EZ BioPac® bag’s unique design and protective skirt reduce or eliminate contamination of the support stand and bag exterior, drastically reducing clean-up requirements

Download Whitepaper

BENEFITS

Ease To Use

EZ BioPac® bags and custom polypropylene support stand allow fast, foolproof set-up

Reduce Fill Time

Large-diameter top opening speeds filling by as much as 71%

Minimize Cleaning

Attached zip ties or ILC Dover’s proprietary crimping system assure complete closure and containment of the bag’s contents

Wide Capacity Range

Bags are available in capacities from 1 to 100 liters to suit full range of plant requirements

Array of Flange Sizes

EZ BioPac® bags offer discharge sanitary flange sizes from 1.5˝ to 8˝ to match a variety of process vessels

EZ BIOPAC®

Issues Of Powder Handling

Media and buffer ingredients used in powder form have historically been transferred from stock containers using open scoops, funnels and bags, then carried and dumped directly into production vessels, since sterility wasn’t required at that early manufacturing stage. While sterility may not be an issue, biopharmaceutical production managers have come to recognize that worker exposure to airborne particulates and the potential for cross-contamination at line change-over can be.


Consequently, they have started to implement single-use systems for powder transfer. Unfortunately, many early systems were simply adapted from liquid-handling systems already in use at the time, and converted to handle powders. These systems often have inherent shortcomings. Instead, production managers should look for systems designed from the ground up to handle biopharmaceutical powders.

Download Brochure

Boosting Profitability With Single-Use Powder Transfer

Many biopharmaceutical manufacturers are implementing single-use containment for transfer of media and buffer materials to prevent feedstock contamination and to promote worker safety. The type of containment system used, however, can have a significant impact on productivity and profitability. Equipment should be evaluated and chosen carefully.

Download Poster

The Keys To Efficient Powder Transfer And Containment

The most efficient powder containment and transfer equipment will feature:

  • A design developed specifically to handle powders
  • Fast filling
  • Easy, complete sealing
  • Fast, clean dispensing
  • Complete product recovery (i.e., no powder left in the container)
  • Self-supporting containers to promote easy handling and distribution


Unlike systems adapted from an existing liquid-handling system,  ILC Dover’s EZ BioPac® system was designed specifically to handle powders in biopharmaceutical applications. The EZ BioPac® system from ILC Dover substantially lessens the amount of powder that disperses into the air, reduces the time needed for changeover, lowers staff costs, and frees staff to work on more vital jobs, which all contribute to profitability.

Contact Local Containment Expert

Tel:  1 (302) 335-3911

Fax: 1 (302) 335-0762

Web:www.ilcdover.com

Go to article: Home | Trust In Big PharmaGo to article: EditorialGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: FreudenbergGo to article: The Pharma Industry BriefingGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: Humira: the highs and lows of the world’s most successful drug Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Gene therapy: talking smart solutions with Bluebird BioGo to article: Moehs Iberica Company InsightGo to article: Moehs Iberica SLGo to article: A research headache: improving the understanding of chronic migraine Go to article: SensitechGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Philanthropy in pharma: a look inside the ISPE FoundationGo to article: DelSiTechGo to article: Novel Oral Therapies Are An Unmet Need For Ulcerative ColitisGo to article: PhoenixGo to article: FDA removes key barrier to US biosimilar developmentGo to article: Nipro PharmaPackagingGo to article: Pfizer price hikes: do rare cancer drugs warrant higher prices?Go to article: AlpexGo to article: Head-to-head: competing for the most effective psoriasis drugGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Takeda to seek label expansion for Ninlaro in multiple myelomaGo to article: Capsugel Company InsightGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s EpidiolexGo to article: EcocoolGo to article: Abiogen PharmaGo to article: Illegal online pharmacies: how endemic are they?Go to article: Global Freight Solutions LtdGo to article: The boom in medical cannabis research is set to continueGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Population boom will boost acute stroke market, particularly in ChinaGo to article: Pall BiotechGo to article: Cryo StoreGo to article: Watch Alibaba instead of Amazon in healthcareGo to article: WIKA - Disaster preventionGo to article: AstraZeneca’s Lynparza maintains lead in PARP inhibitor raceGo to article: G.F.Go to article: Erdmann Design SwitzerlandGo to article: CMV presents a serious concern in HIV+ personsGo to article: BEA TechnologiesGo to article: BaxterGo to article: bDMARD therapy: adherence in the first year is key to successGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: End the struggle: pathways to HEAL the opioid crisisGo to article: LaudaGo to article: AbbVie poised to overtake Gilead as hepatitis C leaderGo to article: ILC Dover IncGo to article: ViiV results show the importance of INIs to future HIV treatmentGo to article: PfanstiehlGo to article: Novartis acquires rights to atopic dermatitis candidate MOR106Go to article: Niconex Medical LtdGo to article: EventsGo to article: Next issue